Finance

Lists
MEOBF:OTCMKTS
Mesoblast Ltd
$1.90
0.00%
(0.00) 1D
Aug 26, 9:30:06 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MEOBF...
Mkt. cap
1.90B
Avg. vol.
33.35K
Volume
0.00
52-wk high
$2.59
52-wk low
$1.30
Beta
1.71
Shares outstanding
1.30B
No. of employees
108
Mkt. cap
1.90B
Avg. vol.
33.35K
Volume
0.00
52-wk high
$2.59
52-wk low
$1.30
Beta
1.71
Shares outstanding
1.30B
No. of employees
108
Profile
Mesoblast Limited is an Australian regenerative medicine company. It seeks to provide treatments for inflammatory ailments, cardiovascular disease, and back pain. The company is led by Silviu Itescu, who founded the company in 2004. Wikipedia
About Mesoblast Ltd
CEOSilviu Itescu
Employees108
Founded2004
Headquarters-
SectorBiotechnology
Websitemesoblast.com
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
25.67M
25.67M
34.45M
34.45M
Cost of goods sold
26.88M
26.88M
-14.87M
-14.87M
Cost of revenue
26.88M
26.88M
-14.87M
-14.87M
Research and development expenses
-
-
45.07M
45.07M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
14.27M
14.27M
14.40M
14.40M
Operating expense
12.95M
12.95M
60.79M
60.79M
Total operating expenses
39.83M
39.83M
45.92M
45.92M
Operating income
-14.16M
-14.16M
-11.47M
-11.47M
Other non operating income
-4.16M
-4.16M
2.61M
2.61M
EBT including unusual items
-19.86M
-19.86M
-8.58M
-8.58M
EBT excluding unusual items
-23.68M
-23.68M
-10.94M
-10.94M
Income tax expense
222.50K
222.50K
84.00K
84.00K
Effective tax rate
-1.12%
-1.12%
-0.98%
-0.98%
Other operating expenses
-1.32M
-1.32M
1.31M
1.31M
Net income
-20.08M
-20.08M
-8.67M
-8.67M
Net profit margin
-78.22%
-78.22%
-25.16%
-25.16%
Earnings per share
-
-
-
-
Interest and investment income
-
-
1.96M
1.96M
Interest expense
-5.64M
-5.64M
-4.29M
-4.29M
Net interest expenses
-5.64M
-5.64M
-2.34M
-2.34M
Depreciation and amortization charges
-
-
-
-
EBITDA
-12.53M
-12.53M
-9.77M
-9.77M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps